Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5247)
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
31,908
Price
$26.29
Total Value
$838.78K
Shares Held After
223,355
% of Holdings
12.5%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,593
Price
$26.31
Total Value
$68.21K
Shares Held After
18,151
% of Holdings
12.5%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
1
Price
$79.95
Total Value
$79.95
Shares Held After
14,012
% of Holdings
0.0%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
58
Price
$79.95
Total Value
$4.64K
Shares Held After
337,427
% of Holdings
0.0%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
70
Price
$79.95
Total Value
$5.60K
Shares Held After
349,140
% of Holdings
0.0%
CASTLE BIOSCIENCES INC (CSTL)
Oelschlager Kristen M — Chief Operating Officer
Shares
200
Price
$34.02
Total Value
$6.80K
Shares Held After
13,356
% of Holdings
1.5%
CASTLE BIOSCIENCES INC (CSTL)
Oelschlager Kristen M — Chief Operating Officer
Shares
3,952
Price
$33.36
Total Value
$131.84K
Shares Held After
13,556
% of Holdings
22.6%
Tempus AI, Inc. (TEM)
Epstein David R — Director
Shares
250
Price
$65.55
Total Value
$16.39K
Shares Held After
30,844
% of Holdings
0.8%
VERACYTE, INC. (VCYT)
Bhanji Muna — Director
Shares
1,864
Price
$42.97
Total Value
$80.10K
Shares Held After
42,718
% of Holdings
4.2%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
400
Price
$89.38
Total Value
$35.75K
Shares Held After
2,845
% of Holdings
12.3%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
6,206
Price
$88.17
Total Value
$547.18K
Shares Held After
3,245
% of Holdings
65.7%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
16,548
Price
$87.20
Total Value
$1.44M
Shares Held After
9,451
% of Holdings
63.6%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
4,845
Price
$86.40
Total Value
$418.61K
Shares Held After
25,999
% of Holdings
15.7%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
2,281
Price
$115.61
Total Value
$263.71K
Shares Held After
9,755
% of Holdings
19.0%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
10,989
Price
$114.71
Total Value
$1.26M
Shares Held After
12,036
% of Holdings
47.7%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
11,730
Price
$113.94
Total Value
$1.34M
Shares Held After
23,025
% of Holdings
33.8%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
600
Price
$321.91
Total Value
$193.14K
Shares Held After
126,019
% of Holdings
0.5%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,400
Price
$320.92
Total Value
$449.29K
Shares Held After
126,619
% of Holdings
1.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,000
Price
$319.76
Total Value
$319.76K
Shares Held After
128,019
% of Holdings
0.8%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
200
Price
$89.04
Total Value
$17.81K
Shares Held After
97,994
% of Holdings
0.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
400
Price
$89.07
Total Value
$35.63K
Shares Held After
552,540
% of Holdings
0.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,016
Price
$88.03
Total Value
$177.47K
Shares Held After
98,194
% of Holdings
2.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
3,700
Price
$88.06
Total Value
$325.82K
Shares Held After
552,940
% of Holdings
0.7%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
4,384
Price
$87.11
Total Value
$381.89K
Shares Held After
100,210
% of Holdings
4.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
8,400
Price
$87.15
Total Value
$732.06K
Shares Held After
556,640
% of Holdings
1.5%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
900
Price
$86.25
Total Value
$77.62K
Shares Held After
104,594
% of Holdings
0.9%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,500
Price
$86.36
Total Value
$215.90K
Shares Held After
565,040
% of Holdings
0.4%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
1,698
Price
$320.99
Total Value
$545.04K
Shares Held After
98,199
% of Holdings
1.7%
SI-BONE, Inc. (SIBN)
DUNN JEFFREY W — Director
Shares
1,367
Price
$18.91
Total Value
$25.85K
Shares Held After
16,057
% of Holdings
7.8%
SI-BONE, Inc. (SIBN)
DUNN JEFFREY W — Director
Shares
18,633
Price
$18.91
Total Value
$352.31K
Shares Held After
17,424
% of Holdings
51.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
29,088
Price
$7.06
Total Value
$205.36K
Shares Held After
4,202,346
% of Holdings
0.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
29,088
Price
$7.06
Total Value
$205.36K
Shares Held After
4,202,346
% of Holdings
0.7%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
584
Price
$14.00
Total Value
$8.18K
Shares Held After
8,617
% of Holdings
6.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
21,688
Price
$98.91
Total Value
$2.15M
Shares Held After
194,440
% of Holdings
10.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
8,312
Price
$98.08
Total Value
$815.24K
Shares Held After
216,128
% of Holdings
3.7%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
3,333
Price
$37.83
Total Value
$126.08K
Shares Held After
96,412
% of Holdings
3.3%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — Chief Commercial Officer
Shares
1,746
Price
$2.26
Total Value
$3.95K
Shares Held After
449,832
% of Holdings
0.4%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — Chief Commercial Officer
Shares
1,530
Price
$2.26
Total Value
$3.46K
Shares Held After
451,578
% of Holdings
0.3%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — Chief Commercial Officer
Shares
2,390
Price
$2.26
Total Value
$5.40K
Shares Held After
453,108
% of Holdings
0.5%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — Chief Commercial Officer
Shares
2,213
Price
$2.26
Total Value
$5.00K
Shares Held After
455,498
% of Holdings
0.5%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science&Techn. Officer
Shares
5,863
Price
$2.26
Total Value
$13.25K
Shares Held After
316,994
% of Holdings
1.8%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science&Techn. Officer
Shares
3,618
Price
$2.26
Total Value
$8.18K
Shares Held After
322,857
% of Holdings
1.1%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science&Techn. Officer
Shares
2,121
Price
$2.26
Total Value
$4.79K
Shares Held After
326,475
% of Holdings
0.6%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science&Techn. Officer
Shares
2,643
Price
$2.26
Total Value
$5.97K
Shares Held After
328,596
% of Holdings
0.8%
Pulmonx Corp (LUNG)
French Glendon E. III — Director
Shares
37,784
Price
$2.26
Total Value
$85.39K
Shares Held After
1,137,936
% of Holdings
3.2%
Pulmonx Corp (LUNG)
French Glendon E. III — Director
Shares
4,098
Price
$2.26
Total Value
$9.26K
Shares Held After
1,175,720
% of Holdings
0.3%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
3,695
Price
$24.27
Total Value
$89.68K
Shares Held After
411,861
% of Holdings
0.9%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
4,933
Price
$23.13
Total Value
$114.10K
Shares Held After
415,556
% of Holdings
1.2%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
5,600
Price
$24.27
Total Value
$135.90K
Shares Held After
420,489
% of Holdings
1.3%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
7,344
Price
$23.12
Total Value
$169.78K
Shares Held After
426,089
% of Holdings
1.7%
Showing 851–900 of 5247 transactions (page 18 of 105)